CP and COVID-19: Additionally, in line with our findings, Stufano et al. proposed MDAs as an independent predictor of long COVID in Italian workers [35], and Restea et al. demonstrated decreased ceruloplasmin levels in patients with type 2 diabetes and severe COVID-19 [36].